Post-SLE classification cells showed upregulation of TOX and downregulation of NFKBIA and TNFAIP3, negative regulators of NF-κB signaling, as well as CD69, an early activation marker (Extended Data Figure 4E). This evidence concerns the gene NFKB1 and systemic lupus erythematosus.